Amani Therapeutics
Biotechnology company developing combination medicines for serious neuropsychiatric disorders.
$25MSeries A
Role not disclosedRI
RTW Investments
Activity from announced rounds
Activity in this selectionSeries A
RTW Investments is the investment manager named in Amani and Encoded financing histories.
Recorded funding activity
Amani develops combination medicines for neuropsychiatric disorders. Encoded develops gene-regulation therapies for neurological disease. The histories refer to the manager rather than a specified RTW fund.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $25M 1 disclosed · full round size, not this investor’s share